| Notifications | Reimbursement for Emergent Inpatient Admissions | MA00.059 | 2/3/2026 3:00 PM | 3/5/2026 | | | 2/3/2026 | This is a New Policy. | | |
| New Policies | Pembrolizumab and berahyaluronidase alfa-pmph (KEYTRUDA QLEX™) | MA08.189 | | 2/2/2026 | | | 2/3/2026 | This is a New Policy. | | |
| New Policies | Chimeric Antigen Receptor T-cell (CAR-T) Therapy: Carvykti® and Abecma® | MA08.190 | | 2/9/2026 | | | 2/9/2026 | This is a New Policy. | | |
| Updated Policies | Spinal Decompression with Interspinous and Interlaminar Devices | MA11.048d | 11/4/2025 11:00 AM | 2/2/2026 | | | 2/3/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Photodynamic Therapy Using Verteporfin (Visudyne®) | MA07.003f | 11/3/2025 12:00 PM | 2/2/2026 | | | 2/3/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Reimbursement for Components of Comprehensive Laboratory Panels | MA01.006b | 10/31/2025 2:00 PM | 2/1/2026 | | | 2/3/2026 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Updated Policies | Chimeric Antigen Receptor (CART) Therapy: Yescarta Tecartus, Breyanzi, Kymriah and Aucatzyl | MA08.093q | | 2/9/2026 | | | 2/9/2026 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Experimental/Investigational Services | MA00.005ar | | 1/1/2026 | | | 2/9/2026 | Medical Coding | | |
| Updated Policies | eviCore Lab Management | MA06.034t | | 1/1/2026 | | | 2/23/2026 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Reissue Policies | Computer-Assisted Musculoskeletal Surgical Navigational Orthopedic Procedure | MA11.088c | | 1/1/2024 | 7/9/2025 | | 2/4/2026 | | | |
| Coding Update | PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative Services | MA00.010av | | 1/1/2026 | | | 2/1/2026 | | 2/1/2026 | |
| Coding Update | Services Paid Above Capitation for Health Maintenance Organization (HMO) and Health Maintenance Organization Point-of-Service (HMO-POS) Primary Care Providers | MA00.033r | | 1/1/2026 | | | 2/3/2026 | | | |
| Coding Update | Laboratory Services for Members Enrolled in Health Maintenance Organization (HMO) or Health Maintenance Organization Point-of-Service (HMO-POS) Products | MA00.030aj | | 1/1/2026 | | | 2/3/2026 | | | |
| Coding Update | Reimbursement for Radiopharmaceutical Agents | MA09.009aa | | 1/1/2026 | | | 2/3/2026 | | | |
| Coding Update | Intravenous Ketamine (Ketalar®) and Intranasal Esketamine (Spravato®) | MA08.137e | | 1/1/2026 | | | 2/11/2026 | | 2/10/2026 | 2/11/2026 |
| Coding Update | Intravenous Ketamine (Ketalar®) and Intranasal Esketamine (Spravato®) | MA08.137e | | 1/1/2026 | | | 2/16/2026 | | | |